A Registered Cohort Study on Duchenne Muscular Dystrophy
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
Dystrophinopathy is a term of X-linked recessive genetic disease, including Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and the X-linked dilated cardiomyopathy. The aim of this study is to determine the clinical spectrum and natural progression of dystrophinopathy in a prospective multicenter natural history study, to assess the clinical, genetic of patients with dystrophinopathy to optimize clinical management.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 2
Healthy Volunteers: f
View:
• Beyond 2 years old
• Diagnosis with Duchenne Muscular Dystrophy, and female carriers, genotypically confirmed
• Diagnosis should be supported by muscle biopsy, if no genetic confirmation.
Locations
Other Locations
China
First Affiliated Hospital of Fujian Medical University
RECRUITING
Fuzhou
Contact Information
Primary
Ning Wang, MD, PhD
ningwang@fjmu.edu.cn
13805015340
Backup
Ming Jin, MD
Safariday@live.com
Time Frame
Start Date: 2019-07-01
Estimated Completion Date: 2049-12-31
Participants
Target number of participants: 2000
Related Therapeutic Areas
Sponsors
Leads: Ning Wang, MD., PhD.